Hong Kong will launch monkeypox vaccination for high-risk groups in October
- Fasting for 16 hours a day may increase the risk of cardiovascular death by 91%
- FDA Approves Groundbreaking Gene Therapy from UK’s Orchard Therapeutics
- Breakthrough in CAR-T therapy: Tumors almost completely disappear in just 5 days
- Adapalene can effectively activate senescence in prostate cancer cells and increase NK cell anti-tumor activity
- mRNA Therapy Unveils Hidden Cancer Cells: BioNTech’s IL-2 Breakthrough
- “Blood Test for Cancer”: Accuracy Up to 83% for Colorectal Cancer
Hong Kong will launch monkeypox vaccination for high-risk groups in October
- Long COVID Brain Fog: Blood-Brain Barrier Damage and Persistent Inflammation
- Japan: Over 10,000 Applications for Health Damage from COVID-19 Vaccines
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- ‘Elixir of Immortality’ Nicotinamide Riboside (NR) Virtually No Effect
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
Hong Kong will launch monkeypox vaccination for high-risk groups in October.
On September 21. The Department of Health of the Hong Kong Government announced on the 21st that the monkeypox vaccination program for high-risk groups will start on October 5, and appointments will be available from October 3.
Hong Kong will launch monkeypox vaccination for high-risk groups in October
In response to an imported case of monkeypox in Hong Kong in September, the SAR government has activated the alert level under the monkeypox preparedness and contingency plan, indicating that the immediate health impact on Hong Kong citizens is low.
The Scientific Committee on Vaccine Preventable Diseases and the Scientific Committee on Emerging Discoveries and Infectious Diseases in Animals (Joint Scientific Committee) under the Centre for Health Protection (CHP) of the Department of Health do not recommend a large-scale monkeypox vaccination programme, the Joint Scientific Committee on 15 September An updated tentative consensus recommendation is published that, on a voluntary basis, the use of third-generation vaccines is recommended for post-exposure vaccination of contacts of confirmed cases, and pre-exposure vaccination of monkeypox for those at high risk of exposure.
Under the program, voluntary monkeypox vaccination is available for high-risk target groups, including those who have engaged in high-risk sexual behaviors, such as having multiple sexual partners, sex workers, and a history of sexually transmitted infections in the past 12 months;
responsible for caring for monkeys Health care workers who have confirmed cases of pox; laboratory workers who handle animal-borne pox viruses; and animal care workers who are at higher risk of exposure when monkeypox cases occur in animals in Hong Kong.
The Department of Health said that starting from October 5, the Department of Health will provide vaccination services for patients with high-risk sexual behaviors at its six social health clinics.
Hong Kong launches monkeypox vaccination for high-risk groups in October
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.